AYAL Capital Advisors’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.09M Sell
775,421
-8,268
-1% -$91.2K 1.92% 14
2026
Q1
$8.99M Buy
783,689
+41,317
+6% +$546K 2.44% 9
2025
Q4
$11.3M Sell
742,372
-87,528
-11% -$1.34M 3.92% 6
2025
Q3
$12.1M Sell
829,900
-113,303
-12% -$1.49M 4.78% 5
2025
Q2
$10.5M Buy
943,203
+403,433
+75% +$5M 2.51% 6
2025
Q1
$8.8M Sell
539,770
-101
-0% -$1.77K 2.91% 8
2024
Q4
$9.43M Sell
539,871
-115,635
-18% -$2.01M 2.42% 5
2024
Q3
$10.2M Sell
655,506
-31,288
-5% -$501K 3.49% 4
2024
Q2
$9.11M Buy
686,794
+63,697
+10% +$873K 3.46% 8
2024
Q1
$9.05M Buy
623,097
+147,855
+31% +$2.04M 3.98% 6
2023
Q4
$6.41M Buy
+475,242
New +$5.58M 2.68% 8

Other funds holding OFIX

AYAL Capital Advisors's OFIX Position: Q2 2026 in Review

AYAL Capital Advisors reduced its Orthofix Medical (OFIX) stake by 1.1% in Q2 2026, selling an estimated $91.2K and leaving 775,421 shares worth $7.09M. The position accounts for 1.92% of the portfolio, ranked #14.

AYAL Capital Advisors first reported a position in OFIX in Q4 2023 and has held it in 11 quarters since. The position peaked at $12.1M in Q3 2025. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • AYAL Capital Advisors held 775,421 shares of Orthofix Medical worth $7.09M as of Q2 2026.
  • AYAL Capital Advisors sold 8,268 Orthofix Medical shares in Q2 2026, an estimated $91.2K.
  • Orthofix Medical made up 1.92% of AYAL Capital Advisors's portfolio in Q2 2026, its #14 holding.
  • AYAL Capital Advisors first reported a position in Orthofix Medical in Q4 2023 and has held it in 11 quarters since.
  • AYAL Capital Advisors's Orthofix Medical position peaked at $12.1M in Q3 2025.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on AYAL Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.